Immutep
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.About IMMP
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).
CEOMarc Voigt
CEOMarc Voigt
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1987
Founded1987
Employees—
Employees—
IMMP Key Statistics
Market cap68.63M
Market cap68.63M
Price-Earnings ratio-1.27
Price-Earnings ratio-1.27
Dividend yield—
Dividend yield—
Average volume1.04M
Average volume1.04M
High today$0.4995
High today$0.4995
Low today$0.4573
Low today$0.4573
Open price$0.4826
Open price$0.4826
Volume854.96K
Volume854.96K
52 Week high$3.53
52 Week high$3.53
52 Week low$0.2928
52 Week low$0.2928
IMMP News
TipRanks 6d
Immutep Faces Securities Lawsuit After 83% Stock Collapse Following Phase III Trial DiscontinuationImmutep Limited (IMMP) said its lung cancer treatment could change everything, according to a lawsuit recently filed. Strong trial data. Strong safety results....
Analyst ratings
67%
of 6 ratingsBuy
33.3%
Hold
66.7%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.